Crystal Clear Acne Treatment Pads

Manufacturer
Skin Pharm, LLC
Effective date
2024-05-22
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:13:03

Label at a glance#

ProductCrystal Clear Acne Treatment Pads
Active ingredientSALICYLIC ACID
Label structure10 sections

Dosage and administration

• clean the skin thoroughly before applying this product • cover the entire affected area one to two times daily, avoiding eye area • allow to absorb before applying additional products • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two times daily if needed or as directed by a doctor • if bothersome dryness or peeling occurs, reduce application to on...

Storage and handling

• store in a cool, dry place. • Sunburn Alert: This product contains an alpha hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing and limit sun exposure while using this product and for a week afterwards.

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Acne treatment

Use

INDICATIONS & USAGE SECTION

for the treatment of acne

Warnings

WARNINGS SECTION

For external use only

When using this product • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

• clean the skin thoroughly before applying this product • cover the entire affected area one to two times daily, avoiding eye area • allow to absorb before applying additional products • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two times daily if needed or as directed by a doctor • if bothersome dryness or peeling occurs, reduce application to once a day or every other day • do not rinse • tighten cap after use to prevent pads from drying out.

Other information

STORAGE AND HANDLING SECTION

• store in a cool, dry place. • Sunburn Alert: This product contains an alpha hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing and limit sun exposure while using this product and for a week afterwards.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water/Aqua/Eau, Lactic Acid, Glycolic Acid, Ethoxydiglycol, Sodium Hydroxide, Glycerin, Morus Alba Root Extract, Glycyrrhiza Glabra (Licorice) Root Extract, Citrus Grandis (Grapefruit) Peel Extract, Tetrasodium EDTA, Cucumis Sativus (Cucumber) Fruit Extract, Chamomilla Recutita (Matricaria) Flower Extract, Aloe Barbadensis Leaf Extract, Beta-Glucan, Dipotassium Glycyrrhizate, Caprylic/Capric Triglyceride, Menthyl Lactate, Ethylhexylglycerin, Allantoin, Phenoxyethanol, PPG-26-Buteth-26, PEG-40 Hydrogenated Castor Oil.

Questions?

OTC - QUESTIONS SECTION

+1-615-582-6726
Mon - Fri, 9:30 AM - 5:30 PM

SPL UNCLASSIFIED SECTION

skin pharm's own

our

HERO PRODUCT

YOU ALL-IN-ONE TO BRIGHTEN SKIN, TIGHTEN PORES + COMBAT BREAKOUTS

salicylic acid
absorbs excess oil

glycolic + lactic acid
support natural collagen

botanical blend
brightens + evens skin tone

bye bye, blemishes

MANUFACTURED FOR SKIN PHARM
NASHVILLE, TN 37212
skinpharm.com

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Acnepad-nw1Acnepad-nw1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
797892salicylic acid 2 % Medicated PadPSN2
797892salicylic acid 20 MG/ML Medicated PadSCD2
797892salicylic acid 2 % Medicated PadSY2
797892salicylic acid 2 % Topical SwabSY2

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83316-001-01Crystal Clear Acne Treatment Pads60 in 1 JARPATCH602
83316-001-01Crystal Clear Acne Treatment Pads1.2 mL in 1 PATCHPATCH1.22
83316-001-02Crystal Clear Acne Treatment Pads1 in 1 CARTONPATCH12
83316-001-02Crystal Clear Acne Treatment Pads60 in 1 JARPATCH602

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83316-001CRYSTAL CLEAR ACNE TREATMENT PADS (SALICYLIC ACID) PATCH [SKIN PHARM, LLC]2Current NDC, 4 package rows20240531_0469b1ab-5cfb-416a-b34b-7dc6fef611ff.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83316-00183316-001-01, 83316-001-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 23 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Crystal Clear Acne Treatment PadsSALICYLIC ACIDSkin Pharm, LLC0469b1ab-5cfb-416a-b34b-7dc6fef611ff2024-05-22WarningsExact identifier
ndc (package): 83316-001-01
ndc (package): 83316-001-02
ndc (product): 83316-001
ndc11 (package): 83316000102
ndc11 (package): 83316000101
spl id: 1a72e726-7316-4cd3-9dcd-292c66baab9d
spl set id: 0469b1ab-5cfb-416a-b34b-7dc6fef611ff

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.